Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Borneol has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Berberine has notoriously low oral availability, held back by efflux and rapid first-pass handling. Borneol has been shown in animal and cell work to loosen tight junctions and raise the apparent permeability of co-dosed compounds. The classical role of borneol in formulas is exactly this, as a guiding agent added in small amounts to carry other constituents. Human pharmacokinetic confirmation of the pair is lacking, so read it as mechanistic.
Animal work reports that borneol transiently increases blood-brain barrier permeability, and formulators have used it alongside neuroactive botanicals for that reason. Nothing has measured ginkgo terpene lactone brain exposure in people with and without borneol. The pairing is a formulation tradition supported by non-human permeability data, not a demonstrated human effect.
Curcumin's problem is solubility and rapid conjugation rather than membrane crossing alone, so a permeation enhancer only addresses part of it. Borneol has been included in experimental nasal and oral delivery systems for exactly this class of molecule. Evidence sits at the formulation-science level.
Menthol is the archetypal TRPM8 agonist and borneol acts on overlapping thermosensitive channels, which is why both read as cooling on skin and mucosa. Combined topically the sensory effect stacks, and so does the irritation potential on broken skin or mucous membranes. This is a sensory and formulation interaction. It says nothing about a systemic effect.
Bornyl esters and borneol itself potentiate GABA-A currents in cell work, and valerenic acid does the same at a different site on the receptor. Combining them in a night-time formula stacks two weak modulators at one receptor complex. Neither has strong human data at supplement doses, and the caution is more about layering sedating agents than about any expected benefit.
Melatonin shifts timing rather than sedating directly, but the practical experience of combining it with a GABA-active terpene is more grogginess than either alone in some people. The interaction is behavioural and unmeasured. Flagged so that anyone layering an evening stack counts both.
Borneol is absorbed quickly and conjugated to borneol glucuronide before renal excretion. Quercetin is heavily glucuronidated on the same enzyme family. High co-doses can in principle slow each other's clearance. This is inferred from shared metabolic route rather than measured for this pair, so the confidence stays low.
Borneol dissolves readily in oils and alcohols and barely at all in water, so any oral or topical preparation needs a lipid or alcoholic vehicle to get it into solution and keep it there. Carrier oils also slow evaporative loss from topical preparations. This is formulation chemistry.
Nothing specific on file for Borneol. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 3 we read for Borneol. The full linked list is below.
5 sources behind our Borneol verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 12,337 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Borneol is, not how risky it is. A report is not proof Borneol caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.